Key result
Glutaraldehyde-treated bioprosthetic mitral valves implanted in juvenile pigs functioned after 6 months, exhibiting calcification and minor thrombotic depositions comparable to sheep models.
Observational (n=8)
Nonblinded
No
The juvenile pig model is a reliable and suitable animal model for long-term preclinical evaluation of bioprosthetic mitral valves, demonstrating comparable degenerative processes to sheep and humans.
Answers are grounded in this paper and cite their sources.
Juvenile pigs may serve as an alternative preclinical model for bioprosthetic mitral valves; leaves open translation to human durability and safety.
BACKGROUND: Glutaraldehyde-treated bioprosthetic heart valves are commonly used for replacement of diseased heart valves. However, calcification and wear limit their durability, and the development of new and improved bioprosthetic valve designs is needed and must be evaluated in a reliable animal model. We studied glutaraldehyde-treated valves 6 months after implantation to evaluate bioprosthetic valve complications in the mitral position in juvenile pigs. MATERIALS: The study material comprised eight, 5-month old, 60-kg pigs. All pigs received a size 27, glutaraldehyde-treated, stented, Carpentier-Edwards S.A.V. mitral valve prosthesis. After six months, echocardiography was performed, and the valves explanted for gross examination, high resolution X-ray, and histological evaluation. RESULTS: Five pigs survived the follow-up period. Preexplant echocardiography revealed a median peak and mean velocity of 1.61 m/s (range: 1.17-2.00) and 1.20 (SD = ±0.25), respectively, and a median peak and mean pressure difference of 10.42 mmHg (range: 5.83-16.55) and 6.51 mmHg (SD = ±2.57), respectively. Gross examination showed minor thrombotic depositions at two commissures in two valves and at all three commissures in three valves. High resolution X-ray imaging revealed different degrees of calcification in all explanted valves, primarily in the commissural and belly areas. In all valves, histological evaluation demonstrated various degrees of fibrous sheath formation, limited immunological infiltration, and no overgrowth of host endothelium. CONCLUSIONS: Bioprosthetic glutaraldehyde-treated mitral valves can be implanted into the mitral position in pigs and function after 6 months. Echocardiographic data, calcification, and histological examinations were comparable to results obtained in sheep models and human demonstrating the suitability of the porcine model.
No takes yet. Share an insight, caveat, or question.
Hønge et al. (2011) conducted an observational in Bioprosthetic mitral valve degeneration (n=8). Carpentier-Edwards S.A.V. mitral valve prosthesis was evaluated on Valve function and degeneration at 6 months. Glutaraldehyde-treated bioprosthetic mitral valves implanted in juvenile pigs functioned after 6 months, exhibiting calcification and minor thrombotic depositions comparable to sheep models.
Synapse has enriched 10 related papers. Consider them for comparative context: